M. Pizzoleo

Effects of Genistein and Hormone‐Replacement Therapy on Bone Loss in Early Postmenopausal Women: A Randomized Double‐Blind Placebo‐Controlled Study

D. Altavilla, F. Squadrito, N. Frisina, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Haemostatic effects of phytoestrogen genistein in postmenopausal women.

A. Gaudio, N. Frisina, A. Gaudio, 2008, Thrombosis research.

Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis

A. Gaudio, N. Frisina, A. Lasco, 2003, Osteoporosis International.

Long-Term Hemostatic Effects of Cholesterol-Lowering Therapy with Atorvastatin

A. Gaudio, N. Frisina, A. Lasco, 2003, Pathophysiology of Haemostasis and Thrombosis.

Osteoprotegerin and Bone Mineral Density in Hemodiafiltration Patients

A. Ruello, A. Romeo, M. Buemi, 2005, Renal failure.

Serum levels of interleukin-16 in lymphoid malignancies

A. Allegra, A. Alonci, C. Musolino, 2007, Leukemia & lymphoma.

Haemostatic variables in arterial hypertension.

N. Frisina, G. Leone, A. Lasco, 1995, Haemostasis.

Increased Indexes of Thrombin Activation in Advanced Stages of Hypertension

N. Frisina, A. Trifiletti, M. Pizzoleo, 2001, Pathophysiology of Haemostasis and Thrombosis.

Clinical and haemostatic effects of intravenous prostaglandin E1 therapy in patients with peripheral arterial occlusive disease.

A. Attinà, A. Trifiletti, M. Pizzoleo, 1999, Panminerva medica.

Evaluation of haemostatic parameters and circadian variations of the haemostatic system in patients with systemic sclerosis and Raynaud's phenomenon.

A. Trifiletti, S. Bartolone, M. Pizzoleo, 2000, Panminerva Medica (Testo stampato).